Two anti-angiogenic TKI-PET tracers, [C-11]axitinib and [C-11]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)612-624
JournalNuclear Medicine and Biology
Volume43
Issue number10
DOIs
Publication statusPublished - Oct 2016

Cite this

@article{cfa8753ec14c4fa99e213b2ab0b77179,
title = "Two anti-angiogenic TKI-PET tracers, [C-11]axitinib and [C-11]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents",
keywords = "Axitinib, Nintedanib, TKI-Pet, Personalized medicine, VEGFR",
author = "Paul Slobbe and Poot, {Alex J.} and Rianne Haumann and Schuit, {Robert C.} and Windhorst, {Albert D.} and {van Dongen}, {Guus A. M. S.}",
year = "2016",
month = "10",
doi = "10.1016/j.nucmedbio.2016.07.003",
language = "English",
volume = "43",
pages = "612--624",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Two anti-angiogenic TKI-PET tracers, [C-11]axitinib and [C-11]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents

AU - Slobbe, Paul

AU - Poot, Alex J.

AU - Haumann, Rianne

AU - Schuit, Robert C.

AU - Windhorst, Albert D.

AU - van Dongen, Guus A. M. S.

PY - 2016/10

Y1 - 2016/10

KW - Axitinib

KW - Nintedanib

KW - TKI-Pet

KW - Personalized medicine

KW - VEGFR

U2 - 10.1016/j.nucmedbio.2016.07.003

DO - 10.1016/j.nucmedbio.2016.07.003

M3 - Article

VL - 43

SP - 612

EP - 624

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 10

ER -